ArticleGenetic epidemiology2026
Multi-Trait GWAS Analyses of Blood Pressure Traits Provide Limited Gains in Locus Discovery or Polygenic Risk Score Performance Compared to Single-Trait GWAS.
Article in Genetic epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
High blood pressure (BP) represents a major cause of life-threatening cardiovascular conditions. GWAS have identified >2000 BP-associated signals. BP-GWAS usually analyze each BP trait individually. However, multi-trait GWAS may yield novel loci and improve polygenic risk scores (PRS) prediction. We explored whether multi-trait BP-GWAS can: (i) find novel loci undetected by single-trait GWAS; (ii) increase heritability estimates; (iii) improve PRS prediction of hypertension within the Lifelines Cohort Study. We investigate the utility of multi-trait GWAS approaches of correlated BP traits (systolic BP, diastolic BP, pulse pressure). We tested two multi-trait methods inputting results from the latest N > 1 million single-trait BP-GWAS: (a) Multi-Trait Analysis of GWAS (MTAG); (b) genomic structural equation modeling (GenomicSEM); and compared results with single-trait results. We only identified one novel locus from multi-trait GWAS: ZNF268. Neither heritability estimates nor PRS performance improved using multi-trait GWAS. In this scenario of complete sample overlap across BP-GWAS, we observed little gain in results from multi-trait BP-GWAS over single-trait BP-GWAS. Our findings quantify the limited benefit of multi-trait methods under this specific setting. Future BP genetic discoveries are more likely to come from larger GWAS adding new cohort data. However, conclusions may differ for other traits, depending on trait-specific genetic architecture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.